Victory Capital Management Inc. lessened its holdings in Phibro Animal Health Corp (NASDAQ:PAHC) by 63.5% in the 2nd quarter, Holdings Channel.com reports. The firm owned 4,441 shares of the company’s stock after selling 7,713 shares during the quarter. Victory Capital Management Inc.’s holdings in Phibro Animal Health were worth $141,000 at the end of the most recent reporting period.
Several other institutional investors have also made changes to their positions in PAHC. California Public Employees Retirement System increased its stake in shares of Phibro Animal Health by 9.5% in the 1st quarter. California Public Employees Retirement System now owns 50,948 shares of the company’s stock valued at $1,681,000 after purchasing an additional 4,424 shares in the last quarter. Great West Life Assurance Co. Can increased its stake in shares of Phibro Animal Health by 6.4% in the 1st quarter. Great West Life Assurance Co. Can now owns 26,909 shares of the company’s stock valued at $887,000 after purchasing an additional 1,608 shares in the last quarter. Summit Global Investments purchased a new position in shares of Phibro Animal Health in the 1st quarter valued at about $776,000. FMR LLC increased its stake in shares of Phibro Animal Health by 82.7% in the 1st quarter. FMR LLC now owns 337,652 shares of the company’s stock valued at $11,143,000 after purchasing an additional 152,853 shares in the last quarter. Finally, WINTON GROUP Ltd purchased a new position in shares of Phibro Animal Health in the 2nd quarter valued at about $367,000. Hedge funds and other institutional investors own 51.70% of the company’s stock.
PAHC stock opened at $21.21 on Wednesday. The company has a current ratio of 3.02, a quick ratio of 1.74 and a debt-to-equity ratio of 1.45. Phibro Animal Health Corp has a 12-month low of $20.00 and a 12-month high of $44.99. The stock has a market cap of $862.46 million, a price-to-earnings ratio of 13.86, a PEG ratio of 4.27 and a beta of 0.88. The business’s 50-day moving average is $23.15 and its 200 day moving average is $29.19.
Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings data on Tuesday, August 27th. The company reported $0.33 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.34 by ($0.01). Phibro Animal Health had a return on equity of 29.99% and a net margin of 6.59%. The firm had revenue of $203.90 million during the quarter, compared to analyst estimates of $206.00 million. During the same quarter in the previous year, the firm posted $0.46 earnings per share. The company’s quarterly revenue was down 3.7% on a year-over-year basis. As a group, equities analysts forecast that Phibro Animal Health Corp will post 1.12 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Wednesday, September 4th were issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 2.26%. The ex-dividend date of this dividend was Tuesday, September 3rd. Phibro Animal Health’s payout ratio is 31.37%.
In other news, Director E Thomas Corcoran acquired 5,000 shares of the stock in a transaction that occurred on Friday, August 30th. The shares were bought at an average cost of $21.21 per share, for a total transaction of $106,050.00. Following the acquisition, the director now owns 15,000 shares in the company, valued at approximately $318,150. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 50.05% of the company’s stock.
Several brokerages recently weighed in on PAHC. Morgan Stanley upgraded Phibro Animal Health from an “underweight” rating to an “equal” rating and lifted their price target for the company from $21.00 to $30.00 in a research note on Thursday, September 5th. They noted that the move was a valuation call. TheStreet lowered Phibro Animal Health from a “b-” rating to a “c+” rating in a research note on Tuesday, September 10th. Bank of America cut their price target on Phibro Animal Health from $29.00 to $18.00 and set an “underperform” rating for the company in a research note on Thursday, August 29th. ValuEngine upgraded Phibro Animal Health from a “sell” rating to a “hold” rating in a research note on Wednesday, October 2nd. Finally, Barclays lowered their price objective on Phibro Animal Health from $25.00 to $18.00 and set an “underweight” rating on the stock in a report on Thursday, August 29th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the stock. Phibro Animal Health currently has an average rating of “Hold” and a consensus price target of $26.60.
Phibro Animal Health Profile
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.
Read More: Google Finance Portfolio
Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corp (NASDAQ:PAHC).
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.